Replies

• HI Lori Thank you so much! I am , as we speak, continuing to complete the development of the Research Training Series videos and modules in preparation for the launch of the new SMHP Research Academy website! Quite an undertaking! And, Lori, your kind words about my research posters meant a lot to me. I was thrilled to meet you! I'm really looking forward to the possibility of collaborating on a future research project with you! We hope to launch this exciting initiative soon! Take Care Melanie
  September 1, 2024

• Hi Melanie, So great to meet you at SMHP, and to learn about the Academy -- and a wonderful initiative for SMHP and for the future! I eagerly await the Academy videos! (And I loved your poster!) Lori Calabrese, MD
  September 1, 2024

• Tanita devices are comparable to InBody in performance. Inbody has a much longer clinical history though. I have used InBody devices for almost 10 years. You can get an at-home model that will serve you just as well as a commercial version if all you need is the data. The commercial devices have printout and history storage options that can be nice but are not completely necessary. An at-home model is $300-$400 vs $6k-$10k for a commercial one.
  August 20, 2024

• Thank you so much for your reply and sharing your experience and expertise. This was very helpful. I will share with my colleague and definitely reach out to you if I have more questions.
  May 9, 2024

• hi Mary, I am sorry to hear about your colleague's breast cancer. I was diagnosed myself at an early age and that is what sent me in this direction of TCR. I have worked with BC patients in my clinic and have one stage 4 patient who is disease free - 4 years out and did follow a ketogenic diet starting upon diagnosis and continued through her conventional treatment using GKI as a marker. Additionally, fasting before chemo was very helpful for her as well. Studies to support this are growing. Many oncologists are not well educated in nutrition unfortunately. You may know of these but just in case, Miriam's book, keto for cancer and clinic site here https://www.dietarytherapies.com/ and this clinic in Turkey- https://chemothermia.com/about/ which has published on this topic. Feel free to message me.
  May 8, 2024

• I forgot, Hgb A1c 5.4%
  May 1, 2024

• Mark, GLP1 are a godsend, if it wasn’t for side effects. After about 18 months on dulaglutide, I developed macular edema and moderate to severe gastroparesis. The latter, at least, helped me get used to OMAD. Metformin does all the right things, but overall weak benefit. My FBS was 123 yesterday, after overnight 12 hrs from last meal. And, 115 this morning after 36 hours fasting. Both my fasting insulin and c-peptide are low. Antibody panel (4 antibodies) all negative. Strict LCHF for 16 months and mostly carnivore for the last 10 months. Wt loss 95 lbs. I guess I need to continue my daily dose of vitamin P (patience), since I’ve been T2DM x nearly 29 years. I was using up to 300 units of insulin daily before starting to be strict. No fatty liver. I haven’t used insulin in ~100 days. I stopped the dulaglutide 10 months ago. BMI 33 and visceral fat 16%, so I still have more to go.
  May 1, 2024

• Thank you! This client actually isn't obese (though he could still have visceral fat that hasn't been measured). He does also fit the phenotype of LADA - not significantly overweight, "normal" insulin and c-peptide, negative GAD antibodies, elevated TPO antibodies with normal thyroid markers. He does have a lot of T2D (possibly some T1D) and other autoimmune family history.
  April 30, 2024

• I have seen LADA in patients with significant abdominal/ visceral obesity with negative antibodies. I believe the mechanism is a paracrine effect, whereby reduced arterial inflow to the pancreas or reduced outflow with venous congestion with localized congestion leads to a high local concentration of insulin/glucagon and then inhibits production. Radiologists have previously demonstrated that stenting the pancreas blood supply open increases arterial inflow and temporarily increases serum insulin measurements until the stenting fails with weight gain.
  April 30, 2024

• Hey Kendrick, Thanks for your answer. I have several patients with very similar lab results as what Andrea reports. I have checked C-peptide in these patients and have found them low or borderline low. In my research, you can have LADA and have negative antibodies. Have you seen this? Also, I have seen patients with hyperglycemia and insulin in the 6 range, C-peptide in the 2 range..... what are you doing with patients like this? I have worked up glucagon as well, and it seems to be elevated in these patients. Would love to hear your thoughts.
  April 30, 2024